OrganaBio’s unique, flexible model combines proprietary and scalable tissue sourcing with advanced processed and highly characterized perinatal and adult tissues (including umbilical cord blood and leukopaks). With the ability to tailor products and services to a customers’ evolving needs, OrganaBio rapidly manufactures a variety of isolated cells such as CD34+ HSCs, T, B & NK Cells, and macrophages from tissues for pre-clinical research use as well as in the manufacturing of clinical-grade cell therapies.